Publication Detail

The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.

Nitric oxide produced by THAL nitric oxide synthase inhibits TGF.

Hong Wang; Oscar A Carretero; Jeffrey L Garvin (Profiled Authors: Oscar A Carretero; Jeffrey L Garvin; Hong Wang)

Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, MI 48202, USA.
Hypertension 2002;39(2 Pt 2):662-6.

Nitric oxide (NO) produced by neuronal NO synthase (nNOS) in the macula densa decreases tubuloglomerular feedback (TGF). NO produced by NOS in the thick ascending limb (THAL) inhibits NaCl transport. We hypothesized that NO produced by NOS in the THAL reaches the macula densa and inhibits TGF. Rabbit afferent arterioles and attached macula densa were simultaneously microperfused in vitro. TGF response was determined by measuring afferent arteriole diameter before and after increasing NaCl in the macula densa perfusate. When the nNOS inhibitor 7-nitroindazole (7-NI) (10 micromol/L) was added to the macula densa lumen, it increased TGF from 2.3 +/- 0.2 to 3.5 +/- 0.5 microm (P<0.02; n=6). In the presence of 7-NI, N(omega)-nitro-L-arginine methyl ester (L-NAME) (1 mmol/L) enhanced TGF from 2.6 +/- 0.3 to 4.0 +/- 0.5 microm (P<0.02; n=6) when the macula densa was perfused orthograde via the THAL, whereas it had no effect on TGF when the macula densa was perfused retrograde via the distal tubule (DT). Inhibition of macula densa soluble guanylate cyclase with LY83583 (1 micromol/L) blocked the effect of NO produced by THAL NOS when the macula densa was perfused via the THAL. We concluded that NO produced by THAL NOS acts as a paracrine factor, reaching the macula densa and inhibiting TGF.

1 Originating Grant

• 1.

  CARRETERO, OSCAR A.

  Autocoids in Hypertension: Pathogenesis and End Organ Damage

  1 September 1982 - 31 January 2018

  NATIONAL HEART, LUNG, AND BLOOD INSTITUTE

  Total Funding: $ 51,980,043

Scientific Context

This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.